FFA
COGT icon

Farther Finance Advisors’s Cogent Biosciences COGT Stock Holding History

Farther Finance Advisors’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.02K Buy
114
+8
+8% +$295 ﹤0.01% 4597
2025
Q4 		$3.77K Buy
106
+30
+39% +$843 ﹤0.01% 4448
2025
Q3 		$1.09K Sell
76
-671
-90% -$7.95K ﹤0.01% 4342
2025
Q2 		$5.36K Buy
747
+395
+112% +$2.19K ﹤0.01% 3333
2025
Q1 		$2.04K Buy
352
+257
+271% +$2.02K ﹤0.01% 3383
2024
Q4 		$741 Hold
95
– – ﹤0.01% 3344
2024
Q3 		$1.03K Hold
95
– – ﹤0.01% 3236
2024
Q2 		$849 Buy
95
+10
+12% +$76 ﹤0.01% 3126
2024
Q1 		$587 Buy
85
+79
+1,317% +$488 ﹤0.01% 2966
2023
Q4 		$35 Buy
+6
New +$46 ﹤0.01% 3416

Other funds holding COGT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Farther Finance Advisors's COGT Position: Q1 2026 in Review

Farther Finance Advisors increased its Cogent Biosciences (COGT) stake by 7.5% in Q1 2026, buying an estimated $295 and bringing the position to 114 shares worth $4.02K. The position accounts for ﹤0.01% of the portfolio, ranked #4597.

Farther Finance Advisors first reported a position in COGT in Q4 2023 and has held it in 10 quarters since. The position peaked at $5.36K in Q2 2025. 305 funds tracked by Wall St. Rank hold COGT as of Q1 2026.

  • Farther Finance Advisors held 114 shares of Cogent Biosciences worth $4.02K as of Q1 2026.
  • Farther Finance Advisors bought 8 Cogent Biosciences shares in Q1 2026, an estimated $295.
  • Cogent Biosciences made up ﹤0.01% of Farther Finance Advisors's portfolio in Q1 2026, its #4597 holding.
  • Farther Finance Advisors first reported a position in Cogent Biosciences in Q4 2023 and has held it in 10 quarters since.
  • Farther Finance Advisors's Cogent Biosciences position peaked at $5.36K in Q2 2025.
  • 305 funds tracked by Wall St. Rank held Cogent Biosciences as of Q1 2026.

Based on Farther Finance Advisors's 13F filing for Q1 2026, filed 7 Apr 2026.